实用肝脏病杂志2016，Vol.19Issue(6)：687-691,5.DOI:10.3969/j.issn.1672-5069.2016.06.012
特利加压素治疗失代偿期乙型肝炎肝硬化患者消退腹水的作用及对肝肾功能的影响
Therapeutic effects of terlipressin in treatment of patients with decompensated cirrhosis resulting from chronic hepatitis B
摘要
Abstract
Objiective To explore the therapeutic effect of telipressin in treatment of patients with decompensated cirrhosis resulting from chronic hepatitis B. Methods 50 patients with decompensated cirrhosis resulting from chronic hepatitis B were admitted to Anhui Provincial Hospital between August 2014 and June 2016. The patients were divided into telipressin treatment group (n=25) and traditional treatment group (n=25) accordng to the different treatment approaches. The urine volume,abdominal perimeter,and the serum levels of alanine aminotransferase (ALT),AST,total bilirubin,alkaline phosphatase (ALP),creatinine, urea nitrogen on day 1,3,7 after treatment were compared between the two groups. Results On day 3 and 7 after treatment,serum levels creatinine in telipressin treatment group were (100.88±28.51) μmol/L and (95.28±25.34) μmol/L, respectively,significantly lower than those in traditional treatment group [(124.34±19.88)μmol/L and (113.99±26.89)μmol/L,P<0.05];serum levels of urea nitrogen in telipressin treatment group were (10.13±4.76)μmol/L and(9.05±4.53)μmol/L,respectively,markedly lower than those in traditional treatment group[(13.12±5.28)μmol/L and (12.34±5.99)μmol/L,P<0.05];urine volumes in telipressin treatment group were (1825.6±613.34) ml and (1990.8±731.16) ml,respectively,much greater than those in traditional treatment group [(1334.42±542.33)ml and (1421.54±698.99) ml,P<0.05];abdominal perimeters in telipressin treatment group were (91.32±7.4) cm and (91.04±7.45) cm,respectively,smaller than those in traditional treatment group [(96.28±6.89)cm and (96.55±7.99) cm,P<0.05];after seven day treatment, ascites subsided in 76.0% in telipressin treatment group (19/25),much higher than 40.0% in patientsin traditional treatment group (10/25,P<0.05);However,serum levels of ALT,AST,ALP,total bilirubin on day 3 and 7 after treatment were not significantly different between the two groups (P>0.05). Conclusion Terlipressin is effective for patients with decompensated cirrhosis resulting from chronic hepatitis B. The treatment can improve renal functions and decrease ascites.关键词
失代偿期肝硬化/特利加压素/肝肾功能/腹水Key words
Decompensated cirrhosis/Terlipressin/Hepatic and renal function/Ascites引用本文复制引用
程亚,乔晓斐,荚卫东..特利加压素治疗失代偿期乙型肝炎肝硬化患者消退腹水的作用及对肝肾功能的影响[J].实用肝脏病杂志,2016,19(6):687-691,5.基金项目
安徽省科技攻关计划项目 （）
